Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review

IntroductionDual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the opt...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 9; no. 6; p. e022271
Main Authors Elliott, Jesse, Kelly, Shannon E, Bai, Zemin, Skidmore, Becky, Boucher, Michel, So, Derek Y F, Wells, George A
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.06.2019
BMJ Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract IntroductionDual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the optimal duration of DAPT following PCI with stenting, with a focus on clinically relevant patient subgroups.Methods and analysisWe will perform a comprehensive search of the published literature for randomised controlled trials (RCTs) assessing the benefits and harms of extended DAPT (>12 months) compared with short-term DAPT (6–12 months) following PCI with stenting (bare metal or drug eluting). ClinicalTrials.gov and ICTRP will also be searched to identify ongoing and completed clinical trials. Two independent reviewers will select studies for inclusion, and the risk of bias will be assessed by use of Cochrane’s Risk of Bias tool. The primary outcome of interest is death (all-cause, cardiovascular, non-cardiovascular). Secondary outcomes are bleeding (major, minor, gastrointestinal), urgent target vessel revascularisation, major adverse cardiovascular events, myocardial infarction, stroke and stent thrombosis. Subgroup data will be sought for patients with prior myocardial infarction, acute coronary syndrome at presentation and diabetes, and based on smoking status and age group. Data will be analysed by random-effects meta-analysis, and separate analyses will be performed for patient subgroups. Bayesian network meta-analysis will be performed to investigate the effect of individual P2Y12 inhibitors at different DAPT durations longer than 6 months.Ethics and disseminationThis review will provide a comprehensive overview of the available evidence of the benefits and harms associated with extending DAPT beyond 12 months following PCI with stenting and the effects on clinically important subgroups. The results of this review will inform clinical and policy decisions regarding the optimal treatment duration of DAPT following PCI with stenting.Systematic review registrationPROSPERO no. CRD42018082587
AbstractList Dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the optimal duration of DAPT following PCI with stenting, with a focus on clinically relevant patient subgroups. We will perform a comprehensive search of the published literature for randomised controlled trials (RCTs) assessing the benefits and harms of extended DAPT (>12 months) compared with short-term DAPT (6-12 months) following PCI with stenting (bare metal or drug eluting). ClinicalTrials.gov and ICTRP will also be searched to identify ongoing and completed clinical trials. Two independent reviewers will select studies for inclusion, and the risk of bias will be assessed by use of Cochrane's Risk of Bias tool. The primary outcome of interest is death (all-cause, cardiovascular, non-cardiovascular). Secondary outcomes are bleeding (major, minor, gastrointestinal), urgent target vessel revascularisation, major adverse cardiovascular events, myocardial infarction, stroke and stent thrombosis. Subgroup data will be sought for patients with prior myocardial infarction, acute coronary syndrome at presentation and diabetes, and based on smoking status and age group. Data will be analysed by random-effects meta-analysis, and separate analyses will be performed for patient subgroups. Bayesian network meta-analysis will be performed to investigate the effect of individual P2Y12 inhibitors at different DAPT durations longer than 6 months. This review will provide a comprehensive overview of the available evidence of the benefits and harms associated with extending DAPT beyond 12 months following PCI with stenting and the effects on clinically important subgroups. The results of this review will inform clinical and policy decisions regarding the optimal treatment duration of DAPT following PCI with stenting. PROSPERO no. CRD42018082587.
IntroductionDual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the optimal duration of DAPT following PCI with stenting, with a focus on clinically relevant patient subgroups.Methods and analysisWe will perform a comprehensive search of the published literature for randomised controlled trials (RCTs) assessing the benefits and harms of extended DAPT (>12 months) compared with short-term DAPT (6–12 months) following PCI with stenting (bare metal or drug eluting). ClinicalTrials.gov and ICTRP will also be searched to identify ongoing and completed clinical trials. Two independent reviewers will select studies for inclusion, and the risk of bias will be assessed by use of Cochrane’s Risk of Bias tool. The primary outcome of interest is death (all-cause, cardiovascular, non-cardiovascular). Secondary outcomes are bleeding (major, minor, gastrointestinal), urgent target vessel revascularisation, major adverse cardiovascular events, myocardial infarction, stroke and stent thrombosis. Subgroup data will be sought for patients with prior myocardial infarction, acute coronary syndrome at presentation and diabetes, and based on smoking status and age group. Data will be analysed by random-effects meta-analysis, and separate analyses will be performed for patient subgroups. Bayesian network meta-analysis will be performed to investigate the effect of individual P2Y12 inhibitors at different DAPT durations longer than 6 months.Ethics and disseminationThis review will provide a comprehensive overview of the available evidence of the benefits and harms associated with extending DAPT beyond 12 months following PCI with stenting and the effects on clinically important subgroups. The results of this review will inform clinical and policy decisions regarding the optimal treatment duration of DAPT following PCI with stenting.Systematic review registrationPROSPERO no. CRD42018082587
Dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the optimal duration of DAPT following PCI with stenting, with a focus on clinically relevant patient subgroups.INTRODUCTIONDual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the optimal duration of DAPT following PCI with stenting, with a focus on clinically relevant patient subgroups.We will perform a comprehensive search of the published literature for randomised controlled trials (RCTs) assessing the benefits and harms of extended DAPT (>12 months) compared with short-term DAPT (6-12 months) following PCI with stenting (bare metal or drug eluting). ClinicalTrials.gov and ICTRP will also be searched to identify ongoing and completed clinical trials. Two independent reviewers will select studies for inclusion, and the risk of bias will be assessed by use of Cochrane's Risk of Bias tool. The primary outcome of interest is death (all-cause, cardiovascular, non-cardiovascular). Secondary outcomes are bleeding (major, minor, gastrointestinal), urgent target vessel revascularisation, major adverse cardiovascular events, myocardial infarction, stroke and stent thrombosis. Subgroup data will be sought for patients with prior myocardial infarction, acute coronary syndrome at presentation and diabetes, and based on smoking status and age group. Data will be analysed by random-effects meta-analysis, and separate analyses will be performed for patient subgroups. Bayesian network meta-analysis will be performed to investigate the effect of individual P2Y12 inhibitors at different DAPT durations longer than 6 months.METHODS AND ANALYSISWe will perform a comprehensive search of the published literature for randomised controlled trials (RCTs) assessing the benefits and harms of extended DAPT (>12 months) compared with short-term DAPT (6-12 months) following PCI with stenting (bare metal or drug eluting). ClinicalTrials.gov and ICTRP will also be searched to identify ongoing and completed clinical trials. Two independent reviewers will select studies for inclusion, and the risk of bias will be assessed by use of Cochrane's Risk of Bias tool. The primary outcome of interest is death (all-cause, cardiovascular, non-cardiovascular). Secondary outcomes are bleeding (major, minor, gastrointestinal), urgent target vessel revascularisation, major adverse cardiovascular events, myocardial infarction, stroke and stent thrombosis. Subgroup data will be sought for patients with prior myocardial infarction, acute coronary syndrome at presentation and diabetes, and based on smoking status and age group. Data will be analysed by random-effects meta-analysis, and separate analyses will be performed for patient subgroups. Bayesian network meta-analysis will be performed to investigate the effect of individual P2Y12 inhibitors at different DAPT durations longer than 6 months.This review will provide a comprehensive overview of the available evidence of the benefits and harms associated with extending DAPT beyond 12 months following PCI with stenting and the effects on clinically important subgroups. The results of this review will inform clinical and policy decisions regarding the optimal treatment duration of DAPT following PCI with stenting.ETHICS AND DISSEMINATIONThis review will provide a comprehensive overview of the available evidence of the benefits and harms associated with extending DAPT beyond 12 months following PCI with stenting and the effects on clinically important subgroups. The results of this review will inform clinical and policy decisions regarding the optimal treatment duration of DAPT following PCI with stenting.PROSPERO no. CRD42018082587.SYSTEMATIC REVIEW REGISTRATIONPROSPERO no. CRD42018082587.
Author Bai, Zemin
So, Derek Y F
Skidmore, Becky
Elliott, Jesse
Boucher, Michel
Wells, George A
Kelly, Shannon E
AuthorAffiliation 3 Independent Information Specialist , Ottawa , Ontario , Canada
1 Cardiovascular Research Methods Centre , University of Ottawa Heart Institute , Ottawa , Ontario , Canada
4 Program and Policy Development , Canadian Agency for Drugs and Technologies in Health (CADTH) , Ottawa , Ontario , Canada
5 University of Ottawa Heart Institute , Ottawa , Ontario , Canada
2 School of Epidemiology and Public Health , University of Ottawa , Ottawa , Ontario , Canada
AuthorAffiliation_xml – name: 4 Program and Policy Development , Canadian Agency for Drugs and Technologies in Health (CADTH) , Ottawa , Ontario , Canada
– name: 2 School of Epidemiology and Public Health , University of Ottawa , Ottawa , Ontario , Canada
– name: 1 Cardiovascular Research Methods Centre , University of Ottawa Heart Institute , Ottawa , Ontario , Canada
– name: 3 Independent Information Specialist , Ottawa , Ontario , Canada
– name: 5 University of Ottawa Heart Institute , Ottawa , Ontario , Canada
Author_xml – sequence: 1
  givenname: Jesse
  orcidid: 0000-0002-2501-1641
  surname: Elliott
  fullname: Elliott, Jesse
  email: gawells@ottawaheart.ca
  organization: School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
– sequence: 2
  givenname: Shannon E
  surname: Kelly
  fullname: Kelly, Shannon E
  email: gawells@ottawaheart.ca
  organization: School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
– sequence: 3
  givenname: Zemin
  surname: Bai
  fullname: Bai, Zemin
  email: gawells@ottawaheart.ca
  organization: Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
– sequence: 4
  givenname: Becky
  surname: Skidmore
  fullname: Skidmore, Becky
  email: gawells@ottawaheart.ca
  organization: Independent Information Specialist, Ottawa, Ontario, Canada
– sequence: 5
  givenname: Michel
  surname: Boucher
  fullname: Boucher, Michel
  email: gawells@ottawaheart.ca
  organization: Program and Policy Development, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Ontario, Canada
– sequence: 6
  givenname: Derek Y F
  surname: So
  fullname: So, Derek Y F
  email: gawells@ottawaheart.ca
  organization: University of Ottawa Heart Institute, Ottawa, Ontario, Canada
– sequence: 7
  givenname: George A
  surname: Wells
  fullname: Wells, George A
  email: gawells@ottawaheart.ca
  organization: School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31209080$$D View this record in MEDLINE/PubMed
BookMark eNqNkl9vFCEUxYmpsX_sJzAxJL74MhWYYWB8MGlq1SZNfNB3wjCX3dmwMAKzzX57WWdtWp_kBQLn_HLv5ZyjEx88IPSGkitK6_ZDv92ECXzFCJUVYYwJ-gKdMdI0VUs4P3lyPkWXKW1IWQ3vOGev0GlNGemIJGdo_XnWDmufx8npDA4yzmuIetpjG5wLD6Nf4QmimbP2EOaETYjB67jHo88Qd1CswX_EUww5mOCKLWKN0z5l2Oo8GhxhN8LDa_TSapfg8rhfoB9fbn_efKvuv3-9u7m-r3pey1wNwhAjrRFM91Z0jeH90JHGaGGlELQXtiV9ZwjlXLadEKAHPYAuSmoHW1-gu4U6BL1RUxy3pVIV9Kj-XIS4UjqWohwoUxBAB6OlhGawVney55xww6xoiTiwPi2sae63MJjSadTuGfT5ix_XahV2quVSdoIVwPsjIIZfM6SstmMy4NwyScVYw2TdlI8o0nf_SDdhjr4M6qCirOF1R4uqXlQmhpQi2MdiKFGHWKhjLNQhFmqJRXG9fdrHo-dvCIrgahEU938RfwPcDMl4
CitedBy_id crossref_primary_10_9778_cmajo_20210119
Cites_doi 10.1016/j.amjcard.2017.03.011
10.1016/j.ijcard.2016.06.070
10.1093/eurheartj/ehu278
10.1016/j.ctrsc.2015.08.003
10.1186/2046-4053-4-1
10.1016/S0140-6736(15)60263-X
10.1371/journal.pmed.1000097
10.1177/0272989X12455847
10.1016/j.amjcard.2016.03.005
10.1093/eurheartj/ehx419
10.1136/bmj.h1618
10.1177/0003319715586500
10.1016/j.cjca.2013.07.001
10.1038/srep13204
10.1097/MJT.0000000000000307
10.1007/s00392-015-0860-1
10.1002/9780470712184
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019
Copyright_xml – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019
DBID 9YT
ACMMV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9-
K9.
KB0
M0R
M0S
M1P
M2M
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1136/bmjopen-2018-022271
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
BMJ Journals
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Consumer Health Database
Health & Medical Collection (Alumni Edition)
Medical Database
Psychology Database
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2044-6055
ExternalDocumentID oai_doaj_org_article_c155e1dca88e4dffa98b5505c2f7607f
10_1136_bmjopen_2018_022271
31209080
bmjopen
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID ---
3V.
4.4
53G
5VS
7RV
7X7
7~R
88E
8FI
8FJ
9YT
ABUWG
ACGFS
ACMMV
ADBBV
ADRAZ
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKNYI
BPHCQ
BTFSW
BTHHO
BVXVI
CCPQU
DIK
DWQXO
EBS
EJD
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
HZ~
K9-
KQ8
M0R
M1P
M2M
M48
M~E
NAPCQ
O9-
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
RHF
RHI
RMJ
RPM
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-b538t-d7c0c8fc72abf794c5bd904ca7f8771b7f60b9c015586977eadadea7941fdf3
IEDL.DBID 9YT
ISSN 2044-6055
IngestDate Tue Oct 22 14:37:43 EDT 2024
Tue Sep 17 21:10:18 EDT 2024
Sat Oct 26 04:39:56 EDT 2024
Thu Oct 10 15:40:27 EDT 2024
Thu Nov 21 21:34:57 EST 2024
Sat Nov 02 12:05:45 EDT 2024
Tue Nov 26 19:30:12 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords dual antiplatelet therapy
percutaneous intervention
dapt
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b538t-d7c0c8fc72abf794c5bd904ca7f8771b7f60b9c015586977eadadea7941fdf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2501-1641
OpenAccessLink http://dx.doi.org/10.1136/bmjopen-2018-022271
PMID 31209080
PQID 2241245391
PQPubID 2040975
ParticipantIDs doaj_primary_oai_doaj_org_article_c155e1dca88e4dffa98b5505c2f7607f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6588972
proquest_miscellaneous_2242834908
proquest_journals_2241245391
crossref_primary_10_1136_bmjopen_2018_022271
pubmed_primary_31209080
bmj_primary_10_1136_bmjopen_2018_022271
PublicationCentury 2000
PublicationDate 2019-06-01
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-06-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationTitle BMJ open
PublicationTitleAlternate BMJ Open
PublicationYear 2019
Publisher BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Palla, Briasoulis, Siddiqui 2017; 24
Cassese, Byrne, Ndrepepa 2015; 104
Moher, Shamseer, Clarke 2015; 4
Dias, Welton, Sutton 2013; 33
Tanguay, Bell, Ackman 2013; 29
Xie, Ding, Miao 2016; 51
D’Ascenzo, Moretti, Bianco 2016; 117
Bittl, Baber, Bradley 2016; 68
Navarese, Andreotti, Schulze 2015; 350
Zhang, Zhu, Zhu 2015; 6
Palmerini, Benedetto, Bacchi-Reggiani 2015; 385
2014; 35
Shah, Rashid, Hwang 2017; 119
Levine, Bates, Mauri 2016; 133
Fei, Tsoi, Cheung 2016; 220
Moher, Liberati, Tetzlaff 2009; 6
Tsoi, Cheung, Cheung 2015; 5
Valgimigli, Bueno, Byrne 2018; 39
Verdoia, Schaffer, Barbieri 2016; 67
2024051713045402000_9.6.e022271.3
2024051713045402000_9.6.e022271.4
2024051713045402000_9.6.e022271.5
D’Ascenzo (2024051713045402000_9.6.e022271.16) 2016; 117
2024051713045402000_9.6.e022271.12
2024051713045402000_9.6.e022271.23
2024051713045402000_9.6.e022271.14
Tsoi (2024051713045402000_9.6.e022271.11) 2015; 5
2024051713045402000_9.6.e022271.1
2024051713045402000_9.6.e022271.10
2024051713045402000_9.6.e022271.21
2024051713045402000_9.6.e022271.2
2024051713045402000_9.6.e022271.22
Fei (2024051713045402000_9.6.e022271.6) 2016; 220
Zhang (2024051713045402000_9.6.e022271.8) 2015; 6
Xie (2024051713045402000_9.6.e022271.9) 2016; 51
Palla (2024051713045402000_9.6.e022271.13) 2017; 24
2024051713045402000_9.6.e022271.18
2024051713045402000_9.6.e022271.19
Bittl (2024051713045402000_9.6.e022271.15) 2016; 68
Moher (2024051713045402000_9.6.e022271.20) 2009; 6
Navarese (2024051713045402000_9.6.e022271.7) 2015; 350
Shah (2024051713045402000_9.6.e022271.17) 2017; 119
References_xml – volume: 68
  year: 2016
  article-title: Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association
  publication-title: Circulation
  contributor:
    fullname: Bradley
– volume: 133
  year: 2016
  article-title: Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease a report of the American College of Cardiology / American heart association task force on clinical practice guidelines
  publication-title: Circulation
  contributor:
    fullname: Mauri
– volume: 119
  start-page: 1723
  year: 2017
  article-title: Meta-analysis of the relative efficacy and safety of oral P2Y12 inhibitors in patients with acute coronary syndrome
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2017.03.011
  contributor:
    fullname: Hwang
– volume: 220
  start-page: 895
  year: 2016
  article-title: Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: meta-analysis of randomized controlled trials
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2016.06.070
  contributor:
    fullname: Cheung
– volume: 35
  start-page: 2541
  year: 2014
  article-title: 2014 ESC/EACTS Guidelines on myocardial revascularization
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehu278
– volume: 6
  start-page: 1
  year: 2015
  article-title: Optimize the duration of DAPT following DES implantation: an updated system review and meta-analysis of 10 randomized trials
  publication-title: Clin Trials Regul Sci Cardiol
  doi: 10.1016/j.ctrsc.2015.08.003
  contributor:
    fullname: Zhu
– volume: 4
  start-page: 1
  year: 2015
  article-title: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
  publication-title: Syst Rev
  doi: 10.1186/2046-4053-4-1
  contributor:
    fullname: Clarke
– volume: 385
  start-page: 2371
  year: 2015
  article-title: Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60263-X
  contributor:
    fullname: Bacchi-Reggiani
– volume: 51
  start-page: 762
  year: 2016
  article-title: Different durations of dual anti-platelet therapy after percutaneous coronary intervention with drug-eluting stents in patients with coronary disease: a systematic review
  publication-title: Chinese Pharm. J
  contributor:
    fullname: Miao
– volume: 6
  year: 2009
  article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000097
  contributor:
    fullname: Tetzlaff
– volume: 33
  start-page: 641
  year: 2013
  article-title: Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials
  publication-title: Med Decis Making
  doi: 10.1177/0272989X12455847
  contributor:
    fullname: Sutton
– volume: 117
  start-page: 1714
  year: 2016
  article-title: Meta-analysis of the duration of dual antiplatelet therapy in patients treated with second-generation drug-eluting stents
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2016.03.005
  contributor:
    fullname: Bianco
– volume: 39
  start-page: 213
  year: 2018
  article-title: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx419
  contributor:
    fullname: Byrne
– volume: 350
  year: 2015
  article-title: Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
  publication-title: BMJ
  doi: 10.1136/bmj.h1618
  contributor:
    fullname: Schulze
– volume: 67
  start-page: 224
  year: 2016
  article-title: Optimal duration of dual antiplatelet therapy after DES implantation: a meta-analysis of 11 randomized trials
  publication-title: Angiology
  doi: 10.1177/0003319715586500
  contributor:
    fullname: Barbieri
– volume: 29
  start-page: 1334
  year: 2013
  article-title: Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2013.07.001
  contributor:
    fullname: Ackman
– volume: 5
  year: 2015
  article-title: Duration of dual antiplatelet therapy after drug-eluting stent implantation: meta-analysis of large randomised controlled trials
  publication-title: Sci Rep
  doi: 10.1038/srep13204
  contributor:
    fullname: Cheung
– volume: 24
  start-page: e468
  year: 2017
  article-title: Long (>12 months) and short (<6 months) versus standard duration of dual antiplatelet therapy after coronary stenting: a systematic review and meta-analysis
  publication-title: Am J Ther
  doi: 10.1097/MJT.0000000000000307
  contributor:
    fullname: Siddiqui
– volume: 104
  start-page: 887
  year: 2015
  article-title: Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-015-0860-1
  contributor:
    fullname: Ndrepepa
– volume: 68
  year: 2016
  ident: 2024051713045402000_9.6.e022271.15
  article-title: Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association
  publication-title: Circulation
  contributor:
    fullname: Bittl
– ident: 2024051713045402000_9.6.e022271.2
  doi: 10.1093/eurheartj/ehu278
– volume: 24
  start-page: e468
  year: 2017
  ident: 2024051713045402000_9.6.e022271.13
  article-title: Long (>12 months) and short (<6 months) versus standard duration of dual antiplatelet therapy after coronary stenting: a systematic review and meta-analysis
  publication-title: Am J Ther
  doi: 10.1097/MJT.0000000000000307
  contributor:
    fullname: Palla
– volume: 117
  start-page: 1714
  year: 2016
  ident: 2024051713045402000_9.6.e022271.16
  article-title: Meta-analysis of the duration of dual antiplatelet therapy in patients treated with second-generation drug-eluting stents
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2016.03.005
  contributor:
    fullname: D’Ascenzo
– ident: 2024051713045402000_9.6.e022271.3
  doi: 10.1093/eurheartj/ehx419
– ident: 2024051713045402000_9.6.e022271.4
– ident: 2024051713045402000_9.6.e022271.5
– ident: 2024051713045402000_9.6.e022271.23
  doi: 10.1177/0272989X12455847
– ident: 2024051713045402000_9.6.e022271.21
– ident: 2024051713045402000_9.6.e022271.14
  doi: 10.1007/s00392-015-0860-1
– volume: 6
  start-page: 1
  year: 2015
  ident: 2024051713045402000_9.6.e022271.8
  article-title: Optimize the duration of DAPT following DES implantation: an updated system review and meta-analysis of 10 randomized trials
  publication-title: Clin Trials Regul Sci Cardiol
  doi: 10.1016/j.ctrsc.2015.08.003
  contributor:
    fullname: Zhang
– volume: 5
  year: 2015
  ident: 2024051713045402000_9.6.e022271.11
  article-title: Duration of dual antiplatelet therapy after drug-eluting stent implantation: meta-analysis of large randomised controlled trials
  publication-title: Sci Rep
  doi: 10.1038/srep13204
  contributor:
    fullname: Tsoi
– ident: 2024051713045402000_9.6.e022271.1
  doi: 10.1016/j.cjca.2013.07.001
– ident: 2024051713045402000_9.6.e022271.12
  doi: 10.1016/S0140-6736(15)60263-X
– ident: 2024051713045402000_9.6.e022271.22
– volume: 350
  year: 2015
  ident: 2024051713045402000_9.6.e022271.7
  article-title: Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
  publication-title: BMJ
  doi: 10.1136/bmj.h1618
  contributor:
    fullname: Navarese
– ident: 2024051713045402000_9.6.e022271.10
  doi: 10.1177/0003319715586500
– ident: 2024051713045402000_9.6.e022271.18
  doi: 10.1186/2046-4053-4-1
– volume: 220
  start-page: 895
  year: 2016
  ident: 2024051713045402000_9.6.e022271.6
  article-title: Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: meta-analysis of randomized controlled trials
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2016.06.070
  contributor:
    fullname: Fei
– volume: 119
  start-page: 1723
  year: 2017
  ident: 2024051713045402000_9.6.e022271.17
  article-title: Meta-analysis of the relative efficacy and safety of oral P2Y12 inhibitors in patients with acute coronary syndrome
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2017.03.011
  contributor:
    fullname: Shah
– volume: 6
  year: 2009
  ident: 2024051713045402000_9.6.e022271.20
  article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000097
  contributor:
    fullname: Moher
– volume: 51
  start-page: 762
  year: 2016
  ident: 2024051713045402000_9.6.e022271.9
  article-title: Different durations of dual anti-platelet therapy after percutaneous coronary intervention with drug-eluting stents in patients with coronary disease: a systematic review
  publication-title: Chinese Pharm. J
  contributor:
    fullname: Xie
– ident: 2024051713045402000_9.6.e022271.19
  doi: 10.1002/9780470712184
SSID ssj0000459552
Score 2.2450602
Snippet IntroductionDual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is...
Dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
bmj
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e022271
SubjectTerms Acute Coronary Syndrome - prevention & control
Acute coronary syndromes
Angioplasty
Cardiovascular disease
Cardiovascular Medicine
Clinical decision making
Decision making
Drug administration
Drug therapy
Dual Anti-Platelet Therapy - methods
Evidence-based medicine
Heart attacks
Humans
Intervention
Meta-analysis
Myocardial Infarction - prevention & control
Patients
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors - therapeutic use
Research Design
Stents
Systematic review
Systematic Reviews as Topic
Thrombosis
Thrombosis - prevention & control
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh9JLSb9St2lRoZBLTSxZtuze-hVCIb00hdyEPsmGZHfZ7lLy7_vGcra7JdAcerVkLM-80bxB0hNjb22sZNRNWzYWQa6kTqQBmUq6glskgCh6KhRPvrXHP9TXs-Zs46ov2hOW5YGz4Q49El4UwduuiyqkZPvOEav2Mum20mmYfSu5UUwNc7Bq-qaRo8yQqNtDd3VB91EBFaIrhxOgAukET7cS0qDbfxvZ_HvP5EYSOtplD0f2yD_kUT9i9-L0Mbt_Mq6PP2Hnn1dohrEm80uQSPiE5wNW1zzB4bNfSFR8Hhd-BU4YUfRzTwoGdnHNJxubH99zkm-YASN4bcEt_6P3zPNZl6fs-9GX00_H5XiXQukwpS3LoH3lu-S1tC4hBn3jQl8pb3XqtBZOp7ZyvScG1bXghACYDdGip0gh1c_YznQ2jc8ZB_2rpQOpDL1Q0aNgEsFKB4uGpJxWBTuAUc08a2WYocaoWzOa35D5TTZ_wd7dGP5u3T-Sc9ZdSRd7eAC0mBEt5l9oKdj-jWvNGKw_DbEYqZq6xzferJsRZrR2kr1BfUDEaJW0YHsZCeuR1HT-GMy7YHoLI1tD3W6ZTs4HKW_wv67X8sX_-LeX7AHM1ed9bPtsZ7lYxVdgTEv3egiO3znDFxc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: PubMed Central
  dbid: RPM
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61PSAuCMorUCojIXEh3cSx44QbtFQV0iIkQOrN8pMu6mZXYVeo_56xnWx3EQfENZ4o1jwy38gznwFeKVdQJ3idc4VBzqjwgQPS5-EK7tKjEzkTCsXpp_riG_t4yS_3gI-zMLFp3-jZSXc9P-lmV7G3cjk3k7FPbPJ5eopZs2kFnezDPqbfrRI9_n4ZbzmnA8NQWdUTPf8RrqJChyibPA5_hvthqjA1muggUWAnLUX2_r9Bzj87J7dS0fl9uDdgSPIu7fUB7LnuEO5Mh1Pyh3B1tsZlVNlseY1QEi1D0pjVDfFo9sUvTFdk6XqzRmTosPQnJvAYqP6GzLZaIN-SQOKwQE_B13qiyC3rM0kTL4_gy_mHr6cX-XCjQq7xx7bKrTCFabwRVGmPkWi4tm3BjBK-EaLUwteFbk3AUU2NyBDdTFmnULL01leP4aBbdO4pEASBFdUILW1bMmewbCqtohqVaz3TgmXwGpUql4kxQ8ZKo6rlYAkZLCGTJTJ4Myr-38TfB-NsRAM7dnyw6L_LwUekwf270hrVNI5Z71Xb6FCJGepFXQifwdFoWjmE7E8ZsAxlvGrxGy83yxhs4QQlWSPIIBwLZ6UZPEmesNnJ6E8ZiB0f2dnq7gr6dyT0Hvz52X-_-Rzuoo7a1MJ2BAerfu1eIFha6eMYHL8Bg1gWuA
  priority: 500
  providerName: National Library of Medicine
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LixQxEA66gngR37auEkHwYrOd9CPdXsTXsgjrRYW5hTzdWXR67J1B9t_7VXdmdkdEvHbSEKq-Sn2VVKoYe25CIYOqm7w2MPJKqkg1IGNOLbhFBIiCo0Dx-FNz9LX6OKtn6cDtLKVVbvbEcaP2vaMz8gNyNbKqy068Xv7MqWsU3a6mFhpX2TUh4cqBZzVT2zMW0JWurmUqNiTK5sD-OKWuVMCGaPPxHaiAU8HXHbc0Vu__G-X8M3Pykis6vMVuJg7J30xKv82uhMUddv043ZLfZSfv1xiGyObL76CS0Ayfnlmd8wi197_grvgyDG4NZhgQ-nNHdQzMcM7nl1IgX3Eq4tADKfht4IZfVH3m04uXe-zz4Ycv747y1FEht9jYVrlXrnBtdEoaG2GJrra-KypnVGyVElbFprCdIx7VNmCGgJnxwWCmiD6W99neol-Eh4yDBJbSglr6TlTBIWwS3kgLifpYWVVl7AWEqpdTxQw9Rhplo5P4NYlfT-LP2MuN4P9v-ltSznYqVcceP_TDN52MTTusPwjvTNuGysdoutZSJOZkVE2hYsb2N6rVyWTP9AXAMvZsOwxjoxuUSRs0B3SM7koz9mBCwnYlJb1CBv_OmNrByM5Sd0cW85OxoDdYYNsp-ejfy3rMbkAQ3ZSnts_2VsM6PAEjWtmnI-x_A_NrDZc
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1di9QwFA3LCuKLrN_VVSIIvlht07RpBRG_lkUYX3Rh30KSJu7IOp3tzqDz7z23zYw7soqvTUrDuff2nkuScxl7YnwmvCqrtDQIcilUIA3IkFIL7jzAibyjQnHyqTo8kh-Py-Mdtu6KGgE8v7S0o35SR_3p859nq9cI-FexI8kL-_0bDcHgeZ0OlztRDl0RSI10xmsS-f7wa5ZlU5Yiqg_95V1kGTzdylODnP9lHPTPo5QXctPBHrseSSV_M3rBDbbjZzfZ1UncNr_FTt4vMQwMp_NTcEuYio_3rlY8wA-6H8hffO57twRV9N3ynDsSNjD9ik8vnIl8yUnVoYPr4LWeG_5bBpqPV2Bus88HH768O0xji4XU4k-3SFvlMlcHp4SxAaHpSts2mXRGhVqp3KpQZbZxRKzqClQRfmdabzAzD20o7rDdWTfz9xgHKyyEBddsm1x6hzoqb42wQLQN0iqZsKcAVc9HCQ09lB5FpSP8muDXI_wJe7YG_v-mvyXjbKaSXPbwoOu_6hh92mH9Pm-dqWsv2xBMU1sqzZwIqspUSNj-2rR67YKayI2QZdHgG483w4g-2lIZrUFzwM9o8zRhd0dP2KykoGvJIOQJU1s-srXU7ZHZ9GRQ-AYtrBsl7v97WQ_YNQDRjAfX9tnuol_6h6BIC_tocPtf7pMSRw
  priority: 102
  providerName: Scholars Portal
Title Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review
URI https://bmjopen.bmj.com/content/9/6/e022271.full
https://www.ncbi.nlm.nih.gov/pubmed/31209080
https://www.proquest.com/docview/2241245391
https://www.proquest.com/docview/2242834908
https://pubmed.ncbi.nlm.nih.gov/PMC6588972
https://doaj.org/article/c155e1dca88e4dffa98b5505c2f7607f
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ta9QwHA66gfhFfF91lgiCXyw2adq0ftvm5hA6RKecn0Je2YneHecdsv_eJ213XkVhX1rapG34vTTPL8nvCSEvtM-5l2WVlRpOLrgMkQMyZHELbhZgRN7GQLE9q04_i_eTcrKVrD6ewWdF9dr8-BY3koI6WZ11qZsIdna5RGATDfrr-WZIBeikKbs9dnguRAagXg48Q_95D_oT3B31SB1x_7_Q5t-LJrd6oZO75M4AH-lBr-975Iaf3Se32mGC_AG5eLtGMaQ1XXwHioRSaJ9hdUkDND7_hZ6KLvzSrgEKPaJ-aiOFgV5e0unW6sc3NPI3zGEkeGxJNf1D-Ez7ZJeH5NPJ8fnRaTZsppAZ_NNWmZM2t3WwkmsT4IS2NK7JhdUy1FIyI0OVm8ZGCFVXAIWwMO28Rk0WXCgekZ3ZfOb3CAX-K7gBqnQNE94iYmJOcwOJuiCMFAl5CaGqRU-Wobogo6jUIH4Vxa968Sfk1ZXgr1f9MCpnUzUSY3c3YC1q8DNl0X7PnNV17YULQTe1iUGY5UFWuQwJ2b9SrRq89aeKMIaLsmjwjeebYvhZnDzptRHrAInFadKEPO4tYdOSIiYgA3onRI5sZNTUcclsetFxeQMA1o3kT64ttKfkNq6afrXaPtlZLdf-GXDRyqTkppzItPOJlOweHLXtF5wPj88-fEy7sQYc300Yjq2o025g6zf9yBFQ
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,21388,24318,27549,27550,27856,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793,73745,74302,77601,77619,77628,77632,77653
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zb9QwEB7BVgJeULkDBYyExAtR41xOeKnopQW6KwRF6pvlk25VNku6K9R_z0zi3XYRQrzGjmTN4fnGHn8D8Fq5JHWiKONCoZPnqfDEAeljasHNPRqRM5Qojsbl8Fv-8aQ4CQduF6Gscrkndhu1bQydkW9TqEnzIqv5zuxnTF2j6HY1tNC4CRvEnF4MYGP3YPz5y-qUBQFLXRRpoBviWbmtf5xRXyq0Dl7F3UtQjmEFv64Fpo6__2-g88_ayWvB6HAT7gYUyd73ar8HN9z0PtwahXvyB3C6v8BhFNpkdo5gEnXD-odWl8yj4ptfGLDYzLVmgdjQYfLPDDEZqPaSTa4VQb5jROPQoK3gby1T7Ir3mfVvXh7C18OD471hHHoqxBq3tnlshUlM5Y1Ilfboi6bQtk5yo4SvhOBa-DLRtSEkVZWIDdHQlHUKZ3JvffYIBtNm6p4AQxiYpRrBpa157gwmTtyqVKNErc-1yCN4g0KVs54zQ3a5RlbKIH5J4pe9-CN4uxT8_03fJeWsphI_dvehab_L4G7S4Podt0ZVlcut96quNOViJvWiTISPYGupWhmc9kJemVgEr1bD6G50h9Jrg-YgIKPb0gge95awWklG75ARgUcg1mxkbanrI9PJaUfpjTiwqkX69N_Legm3h8ejI3n0YfzpGdxBodR91doWDObtwj1HfDTXL4IT_AZS_BHt
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZixQxEC50FhZfxNvWVSMIvthMJ32k2xdx3R3WY4fFA_Yt5HRHdHqcA9l_b1V3ZnZHRHxN0hAqX6W-dCpfATzTPhNellVaanTyQshAGpAhpRLcPCCIvKWD4vG4OvpSvDstT2P-0yKmVa73xG6jdq2lf-RDCjWiKPOGD0NMizg5GL2a_UypghTdtMZyGldhB6NiJgaws384Pvm4-eOC5KUpSxGlh3heDc2Pb1SjCpHC67R7FcoxxGDrVpDqtPz_RkD_zKO8FJhGN-B6ZJTsdQ-Bm3DFT2_B7nG8M78NZwcr7EYDTmbfkVjiOrH-0dU5CwiC9hcGLzbzc7tCnujb1YJZUjXQ83M2uZQQ-ZKRpEOLuMHP5kyzCw1o1r9_uQOfRoef3xylsb5CanCbW6ZO2szWwUqhTUC_tKVxTVZYLUMtJTcyVJlpLLGqukKeiKDTzmscyYML-V0YTNupvw8MKWEuDBJN1_DCWzxEcaeFQYu6UBhZJPAcjapmvX6G6s4deaWi-RWZX_XmT-DF2vD_N3yfFmczlLSyu4Z2_lVF11MW5--5s7qufeFC0E1t6FxmRZBVJkMCe-ulVdGBF-oCbgk83XSj69F9Sr8aNAbJGd2cJnCvR8JmJjm9SUY2noDcwsjWVLd7ppOzTt4bOWHdSPHg39N6AruIf_Xh7fj9Q7iGNmn6BLY9GCznK_8IqdLSPI4-8Bvp9RYa
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dual+antiplatelet+therapy+following+percutaneous+coronary+intervention%3A+protocol+for+a+systematic+review&rft.jtitle=BMJ+open&rft.au=Elliott%2C+Jesse&rft.au=Kelly%2C+Shannon+E&rft.au=Bai%2C+Zemin&rft.au=Skidmore%2C+Becky&rft.date=2019-06-01&rft.pub=BMJ+Publishing+Group+LTD&rft.eissn=2044-6055&rft.volume=9&rft.issue=6&rft.spage=e022271&rft_id=info:doi/10.1136%2Fbmjopen-2018-022271&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon